Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 SGD | +50.00% | +50.00% | +22.45% |
Apr. 15 | Pharmesis’ Attributable Loss for 2023 Widens | MT |
Apr. 15 | Pharmesis International Ltd. Announces the Retirement of Ms. Lin Yimin as a Director | CI |
Business Summary
Sales per Business
SGD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Traditional Chinese Medicine Formulated Drugs
58.4
%
| 8 | 72.9 % | 5 | 58.4 % | -32.75% |
Distribution
21.3
%
| 0 | 0.0 % | 2 | 21.3 % | - |
Western Drugs
20.2
%
| 3 | 27.1 % | 2 | 20.2 % | -37.45% |
Sales per region
SGD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 10 | 100.0 % | 9 | 100.0 % | -16.13% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Xue Dan Wu
CEO | Chief Executive Officer | - | 04-04-15 |
Hui Yee Cheok
SEC | Corporate Secretary | - | 22-05-29 |
Chan Hoe Liang
AUD | Comptroller/Controller/Auditor | - | 16-05-31 |
Lai Yin Chan
SEC | Corporate Secretary | - | 10-06-29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Heng Ching Chew
CHM | Chairman | 73 | 05-11-08 |
Xue Dan Wu
CEO | Chief Executive Officer | - | 04-04-15 |
Yimin Lin
BRD | Director/Board Member | 35 | 23-07-30 |
Yong Teng Seow
BRD | Director/Board Member | 49 | 23-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,600,000 | 6,254,940 ( 22.66 %) | 0 | 22.66 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+22.45% | 2.43M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- BFK Stock
- Company Pharmesis International Ltd.